Ligand Pharmaceuticals Inc insider Jason Aryeh sells $676,158 in LGND shares
An open-market sale between Oct 30 and Nov 2, reported to the SEC on Nov 3, not marked as part of a 10b5-1 plan.
Jason Aryeh sold about $680,000 of Ligand Pharmaceuticals Inc (LGND) stock between Oct 30 and Nov 2, according to an SEC filing. The director received an average of $320.30 for 2,111 shares.
The filing does not mark the sale as made under a Rule 10b5-1 trading plan. The trade was reported within two business days, as Section 16 requires.
After the trade, the filing lists 108,758 shares held.
Figures come from the Form 4 filed with the SEC; the table lists the open-market rows this article covers.
| Company | Ligand Pharmaceuticals Inc (LGND) |
|---|---|
| Insider | Jason Aryeh |
| Role | Director |
| Transaction | Open-market sale (code S) |
| Shares | 2,111 |
| Average price | $320.30 |
| Value | $676,158 |
| Trade dates | Oct 30 to Nov 2, 2026 |
| Filed with the SEC | Nov 3, 2026, 7:39 PM ET |
| Shares held after | 108,758 |
| Ownership | Direct |
| Rule 10b5-1 plan | Not marked in the filing |
See more details on this insider sale
Browse the latest insider selling · See where several insiders traded together
Source: SEC Form 4. Information only, not investment advice. Not affiliated with or endorsed by the U.S. Securities and Exchange Commission.
